DK172273B1 - 2-substituerede-3-hydroxy-1,4-naphthoquioner og fremgangsmåde til fremstilling heraf - Google Patents

2-substituerede-3-hydroxy-1,4-naphthoquioner og fremgangsmåde til fremstilling heraf Download PDF

Info

Publication number
DK172273B1
DK172273B1 DK193584A DK193584A DK172273B1 DK 172273 B1 DK172273 B1 DK 172273B1 DK 193584 A DK193584 A DK 193584A DK 193584 A DK193584 A DK 193584A DK 172273 B1 DK172273 B1 DK 172273B1
Authority
DK
Denmark
Prior art keywords
formula
compounds
compound
hydroxy
group
Prior art date
Application number
DK193584A
Other languages
Danish (da)
English (en)
Other versions
DK193584A (da
DK193584D0 (da
Inventor
Alan Thomas Hudson
Anthony Winchester Randall
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK193584D0 publication Critical patent/DK193584D0/da
Publication of DK193584A publication Critical patent/DK193584A/da
Application granted granted Critical
Publication of DK172273B1 publication Critical patent/DK172273B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30Unsaturated compounds
    • C07C62/34Unsaturated compounds containing ether groups, groups, groups, or groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00Preparation of quinones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00Quinones
    • C07C50/26Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/32Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having two rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/08Saturated compounds having a carboxyl group bound to a six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/15Saturated compounds containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16Unsaturated compounds
    • C07C61/39Unsaturated compounds containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16Unsaturated compounds
    • C07C61/40Unsaturated compounds containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/08Saturated compounds containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/08Saturated compounds containing ether groups, groups, groups, or groups
    • C07C62/10Saturated compounds containing ether groups, groups, groups, or groups with a six-membered ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK193584A 1983-04-14 1984-04-13 2-substituerede-3-hydroxy-1,4-naphthoquioner og fremgangsmåde til fremstilling heraf DK172273B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838310141A GB8310141D0 (en) 1983-04-14 1983-04-14 Naphthoquinone derivatives
GB8310141 1983-04-14

Publications (3)

Publication Number Publication Date
DK193584D0 DK193584D0 (da) 1984-04-13
DK193584A DK193584A (da) 1984-10-15
DK172273B1 true DK172273B1 (da) 1998-02-16

Family

ID=10541105

Family Applications (1)

Application Number Title Priority Date Filing Date
DK193584A DK172273B1 (da) 1983-04-14 1984-04-13 2-substituerede-3-hydroxy-1,4-naphthoquioner og fremgangsmåde til fremstilling heraf

Country Status (17)

Country Link
EP (1) EP0123238B1 (es)
JP (1) JPS59205341A (es)
AT (1) ATE27696T1 (es)
AU (1) AU574353B2 (es)
CY (1) CY1549A (es)
DE (2) DE3464132D1 (es)
DK (1) DK172273B1 (es)
GB (1) GB8310141D0 (es)
HK (1) HK56690A (es)
IL (1) IL71545A (es)
LU (1) LU88579I2 (es)
MX (1) MX9202993A (es)
MY (1) MY102117A (es)
NL (1) NL950002I2 (es)
PH (1) PH22018A (es)
SG (1) SG39390G (es)
ZA (1) ZA842797B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
US5175319A (en) * 1983-04-14 1992-12-29 Burroughs Wellcome Co. Naphthoquinone derivatives
EP0253501A3 (en) * 1986-07-16 1990-04-04 Imperial Chemical Industries Plc N-disubstituted cycloalkylmethyl amines useful as fungicides
DE3801743A1 (de) * 1987-07-03 1989-01-19 Bayer Ag Schaedlingsbekaempfungsmittel auf basis von substituierten 1,4-naphthochinonen und neue substituierte 1,4-naphthochinone
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
AU633836B2 (en) * 1988-08-16 1993-02-11 Wellcome Foundation Limited, The Medicaments
US5225184A (en) * 1988-08-16 1993-07-06 Burroughs Wellcome Co. Medicaments
EP0567162A1 (en) * 1989-09-22 1993-10-27 The Wellcome Foundation Limited Medicaments for the treatment of toxoplasmosis
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
GB8923254D0 (en) * 1989-10-16 1989-12-06 Wellcome Found Medicaments
GB9126874D0 (en) * 1991-12-18 1992-02-19 Wellcome Found Medicaments
GB9207517D0 (en) * 1992-04-06 1992-05-20 Wellcome Found Heterocyclic compounds
GB9216859D0 (en) * 1992-08-07 1992-09-23 Wellcome Found Medicaments
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
US5856362A (en) * 1994-09-02 1999-01-05 Glaxo Wellcome Inc. Medicaments for the treatment of toxoplasmosis
AU2004320912A1 (en) * 2004-07-16 2006-04-27 Usv Limited Novel polymorphs of atovaquone and process of preparation thereof
BRPI0513951A (pt) * 2004-07-30 2008-05-20 Japan Health Science Found agente antiprotozoário
ITMI20070941A1 (it) * 2007-05-09 2008-11-10 Chimico Internazi0Nale S P A L Procedimento per la preparazione di naftochinoni trans2,3-disostituiti
CN101774901B (zh) * 2009-01-09 2012-10-03 武汉泰祥通生物技术有限公司 一种制备阿托伐醌的方法
EP2467358B1 (en) 2009-08-20 2014-07-23 IPCA Laboratories Limited Novel complex for treatment and/or prophylaxis of parasitic infections
GB2476644B (en) 2009-12-23 2012-11-14 Haomamedica Ltd 1,4-Dihydro-1,4-dioxonaphtalene derivatives for the treatment of osteoporosis
EP2651868A2 (en) 2010-12-15 2013-10-23 Glaxo Group Limited Process for the preparation of atovaquone
EP2845588A1 (en) * 2013-09-09 2015-03-11 Centre National de la Recherche Scientifique (C.N.R.S.) PIN1 inhibitors for use in the prevention and/or treatment of theileriosis, and related applications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2553647A (en) * 1946-03-20 1951-05-22 Research Corp Naphthoquinone antimalarials
EG14152A (en) * 1977-11-22 1983-12-31 Wellcome Found Antitheilerial naphtoquinone derivatives

Also Published As

Publication number Publication date
AU574353B2 (en) 1988-07-07
MX9202993A (es) 1992-07-01
IL71545A0 (en) 1984-07-31
IL71545A (en) 1987-12-20
DE19475021I2 (de) 2001-08-02
ZA842797B (en) 1985-11-27
DK193584A (da) 1984-10-15
PH22018A (en) 1988-05-13
AU2679684A (en) 1984-10-18
JPH0533212B2 (es) 1993-05-19
EP0123238A2 (en) 1984-10-31
NL950002I2 (nl) 1998-04-01
EP0123238A3 (en) 1985-10-30
ATE27696T1 (de) 1987-06-15
DE3464132D1 (de) 1987-07-16
GB8310141D0 (en) 1983-05-18
LU88579I2 (fr) 1995-03-01
MY102117A (en) 1992-03-31
NL950002I1 (nl) 1995-03-01
SG39390G (en) 1990-11-23
HK56690A (en) 1990-08-03
CY1549A (en) 1991-03-22
DK193584D0 (da) 1984-04-13
EP0123238B1 (en) 1987-06-10
JPS59205341A (ja) 1984-11-20

Similar Documents

Publication Publication Date Title
DK172273B1 (da) 2-substituerede-3-hydroxy-1,4-naphthoquioner og fremgangsmåde til fremstilling heraf
US5053432A (en) Naphthoquinone derivatives
EP0077551B1 (en) 1.4-naphthoquinones, methods for their preparation, pharmaceutical and veterinary formulations thereof
EP0123239B1 (en) Improvements in or relating to antiprotozoal agents
US5310762A (en) Medicaments
FI78677C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara naftokinoner, och vid foerfarandet anvaendbara mellanprodukter.
US5175319A (en) Naphthoquinone derivatives
US6166046A (en) Combination of atovaquone with proguanil for the treatment of protozoal infections
EP0572615B1 (en) Medicament for the Treatment of Protozoal Infections caused by Babesia
EP0445141B1 (en) Medicaments for the treatment of toxoplasmosis
US5856362A (en) Medicaments for the treatment of toxoplasmosis
US5559156A (en) Method for treating animals infected with Babesia spp.
AU637772B2 (en) Medicament for the treatment of cryptosporidiosis
US6049006A (en) Elevation of HDL cholesterol by N-[2-[(aminothioxomethyl) hydrazono]-2-arylethyl]amides
EP0567162A1 (en) Medicaments for the treatment of toxoplasmosis
EP0018682A1 (en) Oxiranecarboxylic acid ester derivatives, their preparation and their inclusion in lipogenesis inhibiting compositions

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1998 00013, 980324

PUP Patent expired